|
US3051621A
(en)
*
|
1959-10-22 |
1962-08-28 |
Grove Lab Inc |
Gel composition, pressurized container with same, and method of preparation
|
|
US3050443A
(en)
*
|
1960-02-16 |
1962-08-21 |
James F Schuyler |
Headache remedy containing ammonia
|
|
NL262354A
(xx)
*
|
1960-03-17 |
|
|
|
|
US3039928A
(en)
*
|
1960-03-17 |
1962-06-19 |
Abbott Lab |
Stable aqueous isoproteronol compositions
|
|
US3088874A
(en)
*
|
1960-05-23 |
1963-05-07 |
Union Carbide Corp |
Powder aerosol
|
|
US3282781A
(en)
*
|
1960-11-25 |
1966-11-01 |
Merck & Co Inc |
Inhalant compositions
|
|
BE632504A
(xx)
*
|
1962-05-24 |
|
|
|
|
US3169095A
(en)
*
|
1962-10-30 |
1965-02-09 |
Rexall Drug Chemical |
Self-propelling powder-dispensing compositions
|
|
NL302251A
(xx)
*
|
1963-01-28 |
1965-10-11 |
|
|
|
US3710782A
(en)
*
|
1969-10-01 |
1973-01-16 |
Hauser Res And Eng Co |
Method of treating human skin with a composition for electromedical applications
|
|
FI770215A7
(xx)
*
|
1976-01-30 |
1977-07-31 |
Fisons Ltd |
|
|
AU522792B2
(en)
*
|
1977-07-19 |
1982-06-24 |
Fisons Plc |
Pressure pack formulation
|
|
US4352789A
(en)
*
|
1980-03-17 |
1982-10-05 |
Minnesota Mining And Manufacturing Company |
Aerosol compositions containing finely divided solid materials
|
|
US4655231A
(en)
*
|
1984-01-09 |
1987-04-07 |
Advanced Tobacco Products, Inc. |
Snuff and preparation thereof
|
|
US4576949A
(en)
*
|
1984-05-07 |
1986-03-18 |
The Upjohn Company |
Use of 5,6,7,8-tetrahydroquinolines and 5,6-dihydropyrindines as leukotriene and lipoxygenase inhibitors and the novel 3-substituted compounds therein
|
|
EP0213108A3
(de)
*
|
1985-06-26 |
1987-07-15 |
Kurt Dr. Burghart |
Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
|
|
JPH0645538B2
(ja)
*
|
1987-09-30 |
1994-06-15 |
日本化薬株式会社 |
ニトログリセリンスプレー剤
|
|
FR2625677A1
(fr)
*
|
1988-01-07 |
1989-07-13 |
Cosnier Alain |
Composition medicamenteuse destinee a etre administree sous forme d'aerosol
|
|
EP0338670B1
(en)
*
|
1988-03-22 |
1994-05-11 |
FISONS plc |
Pharmaceutical Compositions
|
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5766573A
(en)
*
|
1988-12-06 |
1998-06-16 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5439670A
(en)
*
|
1989-11-28 |
1995-08-08 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
DE4003270A1
(de)
*
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
|
US5118494A
(en)
*
|
1990-03-23 |
1992-06-02 |
Minnesota Mining And Manufacturing Company |
Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
|
US5175152A
(en)
*
|
1990-09-28 |
1992-12-29 |
Singh Nikhilesh N |
Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
|
|
MX9203481A
(es)
*
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
|
US5785952A
(en)
*
|
1990-11-09 |
1998-07-28 |
Glaxo Group Limited |
Aerosol medicament formulation having a surface coating of surfactant
|
|
US5919435A
(en)
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
|
ZA924163B
(en)
|
1991-06-10 |
1993-02-24 |
Schering Corp |
Non-chlorofluorocarbon aerosol formulations
|
|
US5234933A
(en)
*
|
1991-10-31 |
1993-08-10 |
Board Of Governors Of Wayne State University And Vanderbilt University |
Cyclic hydroxamic acids
|
|
CA2421976C
(en)
|
1991-12-12 |
2004-04-20 |
Glaxo Group Limited |
Medicaments
|
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
|
ATE128350T1
(de)
*
|
1991-12-12 |
1995-10-15 |
Glaxo Group Ltd |
Pharmazeutische aerosolformulierung.
|
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
|
IL104068A
(en)
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
|
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
JP3908269B2
(ja)
*
|
1991-12-18 |
2007-04-25 |
スリーエム カンパニー |
懸濁エアゾール製剤
|
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
RO117414B1
(ro)
*
|
1992-12-09 |
2002-03-29 |
Jager Paul D Waterbury |
Compozitie farmaceutica de aerosol in solutie
|
|
DE69408373T2
(de)
*
|
1993-06-01 |
1998-07-16 |
Ono Pharmaceutical Co |
Pentansäurederivate
|
|
EP0640609A1
(en)
*
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
|
|
ES2115887T3
(es)
*
|
1993-12-03 |
1998-07-01 |
Ono Pharmaceutical Co |
Derivados de amidinofenoles con actividad de inhibidores de fosfolipasa a2.
|
|
EP0735884B1
(en)
*
|
1993-12-20 |
2000-04-26 |
Minnesota Mining And Manufacturing Company |
Flunisolide aerosol formulations
|
|
ATE178589T1
(de)
|
1994-09-20 |
1999-04-15 |
Ono Pharmaceutical Co |
Amidinophenol-derivate als protease-hemmende verbindungen
|
|
US5679287A
(en)
*
|
1995-04-28 |
1997-10-21 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
|
US5840213A
(en)
*
|
1995-04-28 |
1998-11-24 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
|
KR980009238A
(ko)
|
1995-07-28 |
1998-04-30 |
우에노 도시오 |
설포닐아미노산 유도체
|
|
ATE226936T1
(de)
*
|
1995-08-08 |
2002-11-15 |
Ono Pharmaceutical Co |
Hydroxamsäurederivate verwendbar zur hemmung von gelatinase
|
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
US5861268A
(en)
*
|
1996-05-23 |
1999-01-19 |
Biomide Investment Limited Partnership |
Method for induction of tumor cell apoptosis with chemical inhibitors targeted to 12-lipoxygenase
|
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
|
GB9616237D0
(en)
*
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
|
US6461591B1
(en)
|
1997-02-05 |
2002-10-08 |
Jago Research Ag |
Medical aerosol formulations
|
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
|
US5891419A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe flunisolide aerosol formulations for oral inhalation
|
|
US5891420A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
|
|
US7153866B1
(en)
*
|
1997-05-27 |
2006-12-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia
|
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
|
JPH11187882A
(ja)
|
1997-12-26 |
1999-07-13 |
Ono Pharmaceut Co Ltd |
新規なポリペプチド、その製造方法、そのポリペプチドをコードするｃＤＮＡ、そのｃＤＮＡからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物
|
|
US6585958B1
(en)
|
1998-07-24 |
2003-07-01 |
Jago Research Ag |
Medicinal aerosol formulations
|
|
US6475467B1
(en)
|
1998-08-04 |
2002-11-05 |
Jago Research Ag |
Medicinal aerosol formulations
|
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
|
US6136294C1
(en)
*
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
|
JP4273407B2
(ja)
|
2001-07-23 |
2009-06-03 |
小野薬品工業株式会社 |
Ｅｐ４アゴニストを有効成分とする骨量低下疾患の治療剤
|
|
NZ534712A
(en)
|
2002-02-19 |
2006-11-30 |
Ono Pharmaceutical Co |
Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
|
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
|
KR20050045946A
(ko)
|
2002-06-25 |
2005-05-17 |
애크럭스 디디에스 피티와이 리미티드 |
비정질 약학적 조성물을 이용한 경피전달속도의 제어
|
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
|
TW200410688A
(en)
|
2002-06-26 |
2004-07-01 |
Ono Pharmaceutical Co |
Therapeutics for diseases from vasoconstriction or vasodilatation
|
|
EP2243493A1
(en)
|
2002-07-03 |
2010-10-27 |
Ono Pharmaceutical Co., Ltd. |
Immunopotentiative composition
|
|
US7820682B2
(en)
|
2002-10-03 |
2010-10-26 |
Ono Pharmaceutical Co., Ltd. |
LPA receptor antagonist
|
|
EP1563845A4
(en)
*
|
2002-10-10 |
2008-02-20 |
Univ Kyoto |
REMEDIES FOR ALLERGIC DISEASES
|
|
DK2465537T3
(en)
|
2002-10-10 |
2016-09-19 |
Ono Pharmaceutical Co |
MICROSPHERE INCLUDING ONO-1301
|
|
KR20050107399A
(ko)
|
2003-01-23 |
2005-11-11 |
오노 야꾸힝 고교 가부시키가이샤 |
인간 ｐｄ-1에 대하여 특이성을 갖는 물질
|
|
KR101078505B1
(ko)
|
2003-03-14 |
2011-10-31 |
오노 야꾸힝 고교 가부시키가이샤 |
질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제
|
|
WO2004092169A1
(ja)
|
2003-04-18 |
2004-10-28 |
Ono Pharmaceutical Co., Ltd. |
スピロピペリジン化合物およびその医薬用途
|
|
US20050107306A1
(en)
*
|
2003-05-16 |
2005-05-19 |
Barr Philip J. |
Treatment of respiratory disease associated with matrix metalloproteases by inhalation of synthetic matrix metalloprotease inhibitors
|
|
WO2006031210A1
(en)
|
2003-05-29 |
2006-03-23 |
Board Of Regents, The University Of Texas Systems |
Jabi as a prognostic marker and a therapeutic target for human cancer
|
|
JP4666257B2
(ja)
|
2003-07-25 |
2011-04-06 |
小野薬品工業株式会社 |
軟骨関連疾患治療剤
|
|
ES2754221T3
(es)
|
2003-08-29 |
2020-04-16 |
Ono Pharmaceutical Co |
Compuesto capaz de unirse al receptor de S1P y uso farmacéutico del mismo
|
|
JP4720502B2
(ja)
|
2003-09-01 |
2011-07-13 |
小野薬品工業株式会社 |
縮環化合物およびその用途
|
|
US20080118442A1
(en)
*
|
2003-09-10 |
2008-05-22 |
Map Pharmaceuticals, Inc. |
Aerosol Formulations for Delivery of Dihydroergotamine to the Systemic Circulations Via Pulmonary Inhalation
|
|
AU2004285447A1
(en)
*
|
2003-10-20 |
2005-05-12 |
Schering Corporation |
Pharmaceutical compositions
|
|
WO2005063704A1
(ja)
|
2003-12-25 |
2005-07-14 |
Ono Pharmaceutical Co., Ltd. |
アゼチジン環化合物およびその医薬
|
|
WO2006004646A1
(en)
*
|
2004-06-28 |
2006-01-12 |
Nektar Therapeutics |
Aerosol formulation comprising nicotine salt
|
|
JP5272310B2
(ja)
|
2004-10-21 |
2013-08-28 |
小野薬品工業株式会社 |
免疫抑制受容体の用途
|
|
BRPI0518283A2
(pt)
*
|
2004-11-24 |
2008-11-11 |
Alcon Inc |
mÉtodo para liberar uma aspersço nasal
|
|
WO2006084041A2
(en)
|
2005-02-02 |
2006-08-10 |
Mitos Pharmaceuticals, Inc. |
Nitroxides for use in treating or preventing diabetes
|
|
DK1901749T3
(en)
|
2005-05-18 |
2016-10-24 |
Raptor Pharmaceuticals Inc |
Aerosolized fluoroquinolones AND USES THEREOF
|
|
US8546423B2
(en)
*
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
EP2656860B1
(en)
*
|
2005-06-17 |
2021-05-05 |
Wisconsin Alumni Research Foundation |
Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
|
|
DK1942108T3
(da)
|
2005-10-28 |
2013-12-09 |
Ono Pharmaceutical Co |
Forbindelse indeholdende basisk gruppe samt anvendelse deraf
|
|
WO2007069565A1
(ja)
|
2005-12-12 |
2007-06-21 |
Ono Pharmaceutical Co., Ltd. |
二環式複素環化合物
|
|
US20100184771A1
(en)
|
2005-12-15 |
2010-07-22 |
Ono Pharmaceutical Co., Ltd. |
Bicyclic Heterocyclic Compound
|
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
|
PT2425820E
(pt)
*
|
2007-02-11 |
2015-08-04 |
Map Pharmaceuticals Inc |
Método de administração terapêutica de dhe para permitir o rápido alívio das enxaquecas ao mesmo tempo que minimiza o perfil de efeitos secundários
|
|
TW200902019A
(en)
|
2007-04-26 |
2009-01-16 |
Ono Pharmaceutical Co |
Dicyclic heterocyclic compound
|
|
DE102008007198A1
(de)
|
2008-02-01 |
2009-08-13 |
Infectopharm Arzneimittel Und Consilium Gmbh |
Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
|
|
CN105520922A
(zh)
|
2008-10-07 |
2016-04-27 |
拉普特制药有限公司 |
用于改进的药物动力学的氟喹诺酮气雾剂制剂
|
|
PT2346509T
(pt)
*
|
2008-10-07 |
2020-08-05 |
Horizon Orphan Llc |
Inalação de levofloxacina para redução da inflamação pulmonar
|
|
TWI469965B
(zh)
|
2008-12-22 |
2015-01-21 |
Ono Pharmaceutical Co |
乙炔基吲哚化合物
|
|
ES2511065T3
(es)
|
2009-06-17 |
2014-10-22 |
Ono Pharmaceutical Co., Ltd. |
Nuevo compuesto imidazopiridina
|
|
US20110171141A1
(en)
*
|
2009-06-26 |
2011-07-14 |
Kellerman Donald J |
Administration of dihydroergotamine mesylate particles using a metered dose inhaler
|
|
PT2473170T
(pt)
|
2009-09-04 |
2019-08-23 |
Horizon Orphan Llc |
Utilização de levofloxacina em aerossol para tratamento de fibrose cística
|
|
US8853277B2
(en)
|
2009-11-30 |
2014-10-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)
|
|
CN103080085B
(zh)
|
2010-06-21 |
2014-08-13 |
小野药品工业株式会社 |
4,4’-[4-氟-7-({4-[4-(3-氟-2-甲基苯基)丁氧基]苯基}乙炔基)-2-甲基-1h-吲哚-1,3-二基]二丁酸的新晶型
|
|
BR112013013551A2
(pt)
|
2010-12-02 |
2016-10-11 |
Ono Pharmaceutical Co |
composto e uso médico do mesmo
|
|
US10092552B2
(en)
|
2011-01-31 |
2018-10-09 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
|
US9353113B2
(en)
|
2011-03-18 |
2016-05-31 |
Ono Pharmaceutical Co., Ltd. |
Tetrahydrocarboline derivative
|
|
WO2013161919A1
(ja)
|
2012-04-26 |
2013-10-31 |
小野薬品工業株式会社 |
Ｔｒｋ阻害化合物
|
|
BR112015019921A2
(pt)
|
2013-02-19 |
2017-07-18 |
Ono Pharmaceutical Co |
composto inibidor de trk
|
|
US20150044288A1
(en)
|
2013-07-31 |
2015-02-12 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
|
NZ722927A
(en)
|
2014-01-10 |
2022-07-29 |
Avalyn Pharma Inc |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
|
EP3099672A4
(en)
|
2014-01-31 |
2017-09-20 |
ONO Pharmaceutical Co., Ltd. |
Fused imidazole compounds
|
|
WO2018101309A1
(ja)
|
2016-11-30 |
2018-06-07 |
大日本住友製薬株式会社 |
Ｗｔ１ヘルパーペプチド及びこれと癌抗原ペプチドコンジュゲート体との組合せ
|
|
US20210100886A1
(en)
|
2017-03-30 |
2021-04-08 |
Sumitomo Dainippon Pharma Co., Ltd. |
Wt1 cancer antigen peptides and peptide conjugates comprising the peptides
|
|
JPWO2019049891A1
(ja)
|
2017-09-06 |
2020-10-15 |
小野薬品工業株式会社 |
Ｔｒｋ阻害剤とキナーゼ阻害剤の併用による癌治療方法
|
|
BR112020024404A2
(pt)
|
2018-05-31 |
2021-03-02 |
Ono Pharmaceutical Co., Ltd. |
biomarcadores para determinar a eficácia de inibidores de checkpoint imunológico
|
|
TW202446772A
(zh)
|
2018-10-11 |
2024-12-01 |
日商小野藥品工業股份有限公司 |
Ｓｔｉｎｇ促效化合物
|
|
WO2021025031A1
(ja)
|
2019-08-05 |
2021-02-11 |
小野薬品工業株式会社 |
免疫チェックポイント阻害薬の有効性判定バイオマーカー
|
|
JPWO2021107125A1
(xx)
|
2019-11-29 |
2021-06-03 |
|
|
|
CA3167312A1
(en)
|
2020-02-07 |
2021-08-12 |
Stephen J. Lewis |
Compositions and methods for attenuating opioid induced cardio and/or respiratory depression
|
|
EP4134134A4
(en)
|
2020-04-10 |
2023-12-27 |
ONO Pharmaceutical Co., Ltd. |
STING AGONISTIC COMPOUND
|
|
AU2021272616A1
(en)
|
2020-05-12 |
2022-12-15 |
International Institute Of Cancer Immunology, Inc. |
Pharmaceutical composition for treating cancer
|
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
|
WO2022251679A1
(en)
|
2021-05-27 |
2022-12-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide radicals for use as antiviral treatment for coronavirus infection
|
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|